Hour of Personalized Medicine

This approach relies upon perceiving the genetic, epigenomic, and clinical information that allows the revelations in our understanding of how a person’s unique genomic portfolio makes them vulnerable to certain diseases. It helps in predicting which medical treatments will be safe and effective for the individual patient. It is one of the growing fields where the physician can select a treatment based on the patient’s genetic profile which will automatically increase the positive outcomes and reduces the harmful side effects. PM may assemble the ampleness of existing meds and invalidate the regular issues identified with the non-PM approach. The different results identified with the experimentation approach incorporate medication harmfulness, drug cooperation, misdiagnosis, receptive treatment, drug toxicity, drug interaction, misdiagnosis, and patient dissatisfaction. This approach reduces the dependence on the non-PM trial and error approach for disease treatment.

The goal of personalized medicine includes prevention and not the only treatment. Using molecular stratification of patients like an assessment of mutations that gave rise to resistance to certain medicines helps medical providers to make treatment plans accordingly for individual patients. Currently, the trend which is followed today is that when prescribed medicine is not effective, the patient may then switch to another medication which delays the effective treatment and can lead to the progression of the disease. Powerful utilization of PM depends vigorously on the accessibility of thorough indicative devices that take into account the ideal choice of restorative items to improve quiet results. As indicated by the FDA, the point of PM is to raise benefits and decrease dangers to patients by focusing on avoidance and treatment all the more viably. PM doesn’t try to set up novel medicine for patients, however, to delineate people into subpopulations that differ in their reaction to a helpful specialist for their particular ailment.

Now the question is, if it is so holistic and beneficial then what’s stopping the healthcare providers from deploying it? Well, there are small hiccups in its execution like getting the right data to doctors, accessibility and affordability of next-gen sequencing for community hospitals, approvals from regulating body and a universal body to regularize and regulate the practice. Yes, the same old with all pathbreaking models.

Although the approach is currently plagued by numerous legal and ethical bindings and dilemmas, if incorporated in traditional medicine, the future of personalized medicine will open many doors for pharmaceutical companies for developing molecular-targeted therapeutics and additionally will enhance the optimum use and repurposing of existing medications and combination therapies. It will alter the approach towards the diagnosis and treatment and will increase patient participation during and after the treatment process hence, help provide a tailor-fit delivery of care suited for individual needs, benefitting the practitioners and patients alike.